87 related articles for article (PubMed ID: 15569989)
21. Identification of a chemoprevention cohort from a population of women at high risk for breast cancer.
Fabian CJ; Kamel S; Zalles C; Kimler BF
J Cell Biochem Suppl; 1996; 25():112-22. PubMed ID: 9027607
[TBL] [Abstract][Full Text] [Related]
22. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
23. Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ.
Namba R; Young LJ; Maglione JE; McGoldrick ET; Liu S; Wurz GT; DeGregorio MW; Borowsky AD; MacLeod CL; Cardiff RD; Gregg JP
Breast Cancer Res; 2005; 7(6):R881-9. PubMed ID: 16280035
[TBL] [Abstract][Full Text] [Related]
24. A phase 2a study of topical perillyl alcohol cream for chemoprevention of skin cancer.
Stratton SP; Alberts DS; Einspahr JG; Sagerman PM; Warneke JA; Curiel-Lewandrowski C; Myrdal PB; Karlage KL; Nickoloff BJ; Brooks C; Saboda K; Yozwiak ML; Krutzsch MF; Hu C; Lluria-Prevatt M; Dong Z; Bowden GT; Bartels PH
Cancer Prev Res (Phila); 2010 Feb; 3(2):160-9. PubMed ID: 20103724
[TBL] [Abstract][Full Text] [Related]
25. Perillyl alcohol inhibits human breast cancer cell growth in vitro and in vivo.
Yuri T; Danbara N; Tsujita-Kyutoku M; Kiyozuka Y; Senzaki H; Shikata N; Kanzaki H; Tsubura A
Breast Cancer Res Treat; 2004 Apr; 84(3):251-60. PubMed ID: 15026623
[TBL] [Abstract][Full Text] [Related]
26. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
Masood S; Loya A; Khalbuss W
Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
[TBL] [Abstract][Full Text] [Related]
27. Perillyl alcohol-mediated inhibition of lung cancer cell line proliferation: potential mechanisms for its chemotherapeutic effects.
Xu M; Floyd HS; Greth SM; Chang WC; Lohman K; Stoyanova R; Kucera GL; Kute TE; Willingham MC; Miller MS
Toxicol Appl Pharmacol; 2004 Mar; 195(2):232-46. PubMed ID: 14998688
[TBL] [Abstract][Full Text] [Related]
28. A model to predict the risk of upgrade to malignancy at surgery in atypical breast lesions discovered on percutaneous biopsy specimens.
Uzan C; Mazouni C; Ferchiou M; Ciolovan L; Balleyguier C; Mathieu MC; Vielh P; Delaloge S
Ann Surg Oncol; 2013 Sep; 20(9):2850-7. PubMed ID: 23702641
[TBL] [Abstract][Full Text] [Related]
29. Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up.
Mahoney MC; Robinson-Smith TM; Shaughnessy EA
AJR Am J Roentgenol; 2006 Oct; 187(4):949-54. PubMed ID: 16985141
[TBL] [Abstract][Full Text] [Related]
30. Pilot study of rosiglitazone therapy in women with breast cancer: effects of short-term therapy on tumor tissue and serum markers.
Yee LD; Williams N; Wen P; Young DC; Lester J; Johnson MV; Farrar WB; Walker MJ; Povoski SP; Suster S; Eng C
Clin Cancer Res; 2007 Jan; 13(1):246-52. PubMed ID: 17200362
[TBL] [Abstract][Full Text] [Related]
31. A phase II chemoprevention trial design to identify surrogate endpoint biomarkers in breast cancer.
Dhingra K
J Cell Biochem Suppl; 1995; 23():19-24. PubMed ID: 8747374
[TBL] [Abstract][Full Text] [Related]
32. Phase I clinical trial of perillyl alcohol administered daily.
Ripple GH; Gould MN; Stewart JA; Tutsch KD; Arzoomanian RZ; Alberti D; Feierabend C; Pomplun M; Wilding G; Bailey HH
Clin Cancer Res; 1998 May; 4(5):1159-64. PubMed ID: 9607573
[TBL] [Abstract][Full Text] [Related]
33. Insulin-like growth factor receptor-1 (IGF-1R) expression in normal breast, proliferative breast lesions, and breast carcinoma.
Bhargava R; Beriwal S; McManus K; Dabbs DJ
Appl Immunohistochem Mol Morphol; 2011 May; 19(3):218-25. PubMed ID: 21217522
[TBL] [Abstract][Full Text] [Related]
34. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?
Middleton LP; Grant S; Stephens T; Stelling CB; Sneige N; Sahin AA
Mod Pathol; 2003 Feb; 16(2):120-9. PubMed ID: 12591964
[TBL] [Abstract][Full Text] [Related]
35. Effects of alpha-difluoromethylornithine on markers of proliferation, invasion, and apoptosis in breast cancer.
Izbicka E; Streeper RT; Yeh IT; Pressley O; Grant M; Andrews JV; Kuhn J; O'Shaughnessy J
Anticancer Res; 2010 Jun; 30(6):2263-9. PubMed ID: 20651378
[TBL] [Abstract][Full Text] [Related]
36. Breast cytology and biomarkers obtained by random fine needle aspiration: use in risk assessment and early chemoprevention trials.
Fabian CJ; Zalles C; Kamel S; Zeiger S; Simon C; Kimler BF
J Cell Biochem Suppl; 1997; 28-29():101-10. PubMed ID: 9589354
[TBL] [Abstract][Full Text] [Related]
37. A phase I trial of perillyl alcohol in patients with advanced solid tumors.
Azzoli CG; Miller VA; Ng KK; Krug LM; Spriggs DR; Tong WP; Riedel ER; Kris MG
Cancer Chemother Pharmacol; 2003 Jun; 51(6):493-8. PubMed ID: 12695855
[TBL] [Abstract][Full Text] [Related]
38. Breast carcinogenesis. Transition from hyperplasia to invasive lesions.
Meteoglu I; Dikicioglu E; Erkus M; Culhaci N; Kacar F; Ozkara E; Uyar M
Saudi Med J; 2005 Dec; 26(12):1889-96. PubMed ID: 16380768
[TBL] [Abstract][Full Text] [Related]
39. Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day.
Ripple GH; Gould MN; Arzoomanian RZ; Alberti D; Feierabend C; Simon K; Binger K; Tutsch KD; Pomplun M; Wahamaki A; Marnocha R; Wilding G; Bailey HH
Clin Cancer Res; 2000 Feb; 6(2):390-6. PubMed ID: 10690515
[TBL] [Abstract][Full Text] [Related]
40. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
Tsutsumi Y
Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
